Xianyao Xu1, Jennifer L Philip1, Md Abdur Razzaque1, James W Lloyd2, Charlie M Muller2, Shahab A Akhter3. 1. Division of Cardiothoracic Surgery, Department of Surgery, University of Wisconsin School of Medicine and Public Health, Madison, Wis. 2. University of Chicago Pritzker School of Medicine, Chicago, Ill. 3. Division of Cardiothoracic Surgery, Department of Surgery, University of Wisconsin School of Medicine and Public Health, Madison, Wis. Electronic address: akhter@surgery.wisc.edu.
Abstract
OBJECTIVES: Cardiac ischemia-reperfusion (I-R) injury remains a significant problem as there are no therapies available to minimize the cell death that can lead to impaired function and heart failure. We have shown that high-molecular-weight polyethylene glycol (PEG) (15-20 kD) can protect cardiac myocytes in vitro from hypoxia-reoxygenation injury. In this study, we investigated the potential protective effects of PEG in vivo. METHODS: Adult rats underwent left anterior descending artery occlusion for 60 minutes followed by 48 hours or 4 weeks of reperfusion. One milliliter of 10% PEG solution or phosphate-buffered saline (PBS) control (n = 10 per group) was administered intravenously (IV) immediately before reperfusion. RESULTS: Fluorescein-labeled PEG was robustly visualized in the myocardium 1 hour after IV delivery. The PEG group had significant recovery of left ventricular ejection fraction at 4 weeks versus a 25% decline in the PBS group (P < .01). There was 50% less LV fibrosis in the PEG group versus PBS with smaller peri-infarct and remote territory fibrosis (P < .01). Cell survival signaling was upregulated in the PEG group with increased Akt (3-fold, P < .01) and ERK (4-fold, P < .05) phosphorylation compared to PBS controls at 48 hours. PEG also inhibited apoptosis as measured by TUNEL-positive nuclei (56% decrease, P < .02) and caspase 3 activity (55% decrease, P < .05). CONCLUSIONS: High-molecular-weight PEG appears to have a significant protective effect from I-R injury in the heart when administered IV immediately before reperfusion. This may have important clinical translation in the setting of acute coronary revascularization and myocardial protection in cardiac surgery.
OBJECTIVES: Cardiac ischemia-reperfusion (I-R) injury remains a significant problem as there are no therapies available to minimize the cell death that can lead to impaired function and heart failure. We have shown that high-molecular-weight polyethylene glycol (PEG) (15-20 kD) can protect cardiac myocytes in vitro from hypoxia-reoxygenation injury. In this study, we investigated the potential protective effects of PEG in vivo. METHODS: Adult rats underwent left anterior descending artery occlusion for 60 minutes followed by 48 hours or 4 weeks of reperfusion. One milliliter of 10% PEG solution or phosphate-buffered saline (PBS) control (n = 10 per group) was administered intravenously (IV) immediately before reperfusion. RESULTS:Fluorescein-labeled PEG was robustly visualized in the myocardium 1 hour after IV delivery. The PEG group had significant recovery of left ventricular ejection fraction at 4 weeks versus a 25% decline in the PBS group (P < .01). There was 50% less LV fibrosis in the PEG group versus PBS with smaller peri-infarct and remote territory fibrosis (P < .01). Cell survival signaling was upregulated in the PEG group with increased Akt (3-fold, P < .01) and ERK (4-fold, P < .05) phosphorylation compared to PBS controls at 48 hours. PEG also inhibited apoptosis as measured by TUNEL-positive nuclei (56% decrease, P < .02) and caspase 3 activity (55% decrease, P < .05). CONCLUSIONS: High-molecular-weight PEG appears to have a significant protective effect from I-R injury in the heart when administered IV immediately before reperfusion. This may have important clinical translation in the setting of acute coronary revascularization and myocardial protection in cardiac surgery.
Authors: Vesta Valuckaite; Olga Zaborina; Jason Long; Martin Hauer-Jensen; Junru Wang; Christopher Holbrook; Alexander Zaborin; Kenneth Drabik; Mukta Katdare; Helena Mauceri; Ralph Weichselbaum; Millicent A Firestone; Ka Yee Lee; Eugene B Chang; Jeffrey Matthews; John C Alverdy Journal: Am J Physiol Gastrointest Liver Physiol Date: 2009-10-15 Impact factor: 4.052
Authors: Vesta Valuckaite; John Seal; Olga Zaborina; Maria Tretiakova; Giuliano Testa; John C Alverdy Journal: J Surg Res Date: 2013-03-14 Impact factor: 2.192
Authors: Thierry Hauet; Jean Michel Goujon; Hervé Baumert; Isabelle Petit; Michel Carretier; Michel Eugene; Alain Vandewalle Journal: Kidney Int Date: 2002-08 Impact factor: 10.612
Authors: Laura C Burlage; Alexandre G Lellouch; Corentin B Taveau; Philipp Tratnig-Frankl; Casie A Pendexter; Mark A Randolph; Robert J Porte; Laurent A Lantieri; Shannon N Tessier; Curtis L Cetrulo; Korkut Uygun Journal: J Surg Res Date: 2021-10-17 Impact factor: 2.192
Authors: Mohamed Bejaoui; Eirini Pantazi; Maria Calvo; Emma Folch-Puy; Anna Serafín; Gianfranco Pasut; Arnau Panisello; René Adam; Joan Roselló-Catafau Journal: Oxid Med Cell Longev Date: 2016-02-15 Impact factor: 6.543
Authors: João S Teodoro; Rui T Da Silva; Ivo F Machado; Arnau Panisello-Roselló; Joan Roselló-Catafau; Anabela P Rolo; Carlos M Palmeira Journal: Cells Date: 2022-02-16 Impact factor: 6.600
Authors: Rui Teixeira da Silva; Ivo F Machado; João S Teodoro; Arnau Panisello-Roselló; Joan Roselló-Catafau; Anabela P Rolo; Carlos M Palmeira Journal: Int J Mol Sci Date: 2022-01-21 Impact factor: 5.923